Compared to developed countries, the incidence of colon cancer in China is low, but there is a clear trend of increasing incidence and growing economic burden but its incidence is showing a significant upward trend, and the economic burden is increasing [ 4 ].
← all excerpts
Hsa-miR-181a-2-3p inhibits the oncogenicity of colon cancer by directly targeting STING.
1
—
—